Research & Development



超碰公开 “你猜,”她接著說,“我推開門時看到了什麼……”超碰最新 他奇怪他自己為什麼到北海來了,不,他也不是懊悔,清早里松蔭底下發著涼香,誰懊悔到這里來?他感著像青草般在接受露水的滋潤,他居然感著舒快。奢侈的金黃色的太陽橫著射過他的輝焰,湖水像錦,蓮花蓮葉並著肩挨擠成一片,像在爭著朝覲這早上的雲天!這富足,這綺麗的天然,誰敢不耐煩?維杉到五龍亭邊坐下掏出他的煙卷,低著頭想要仔細地細想一些事,去年的,或許前年的,好多年前的事——今早他又像回到許多年前去——可是他總想不出一個所以然來。“本來是,又何必想?要活著就別想!這又是?誰說過的話……”超碰公开免费视频

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo